CLPT Stock Analysis: Buy, Sell, or Hold?
CLPT - ClearPoint Neuro, Inc. Common Stock
$12.93
-0.49 (-3.65%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
25d
Get Alerted When CLPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called CLPT this week
83% bullish • 1 bearish
83% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CLPT is down 17.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CLPT is down 17.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CLPT is currently trading at $12.93, which is considered oversold relative to its 30-day fair value range of $13.66 to $15.09.
Technical Outlook: Technically, CLPT is in a downtrend. The price is currently testing key support at $12.80. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.00 (+116.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLPT is in a downtrend. The price is currently testing key support at $12.80. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.00 (+116.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$13.66 -
$15.09
Company Quality Score
49/100
(HOLD)
Options IV Signal
40th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
75.8%
Protect Your Profits
Holding CLPT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 40th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.7%)
- BULLISH: Trading 116.1% below Wall St target ($29.00)
- WARNING: Recommendation downgraded due to -17.5% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$13.66 -
$15.09
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.77
(13.7%)
Support & Resistance Levels
Support Level
$12.80
Resistance Level
$16.50
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-16.67
Wall Street Target
$29.00
(+116.1%)
Revenue Growth (YoY)
9.1%
Profit Margin
-67.4%
Last updated: January 30, 2026 5:53 PM ET
Data refreshes hourly during market hours. Next update: 6:53 PM
Data refreshes hourly during market hours. Next update: 6:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Joseph Burnett
SELL
26463 shares
2025-10-10
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced CLPT Option Strategies
Professional options setups generated by AI based on today's CLPT price and gamma walls.
